Cytokinetics | CYTK - Selling And Administration Expenses



Cytokinetics reported $65.72M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Acadia Pharmaceuticals USD 123.66M 2.71M Jun/2025
Amgen USD 1.69B 4M Jun/2025
Bayer EUR 3.55B 162M Jun/2025
Biogen USD 583.8M 11.3M Jun/2025
Bristol-Myers Squibb USD 1.71B 129M Jun/2025
Cytokinetics USD 65.72M 8.35M Jun/2025
Eisai JPY 100.16B 6.34B Jun/2025
Eli Lilly USD 2.75B 390.8M Jun/2025
Exelixis USD 134.86M 2.32M Jul/2025
Geron USD 38.56M 1.46M Jun/2025
Halozyme Therapeutics USD 33M 9.36M Jun/2025
Ionis Pharmaceuticals USD 90.6M 14.6M Jun/2025
Ligand Pharmaceuticals USD 20.18M 1.37M Jun/2025
Merck USD 2.63B 104M Jun/2025
Novartis USD 3.44B 384M Jun/2025
Pfizer USD 3.42B 406M Jun/2025
Regeneron Pharmaceuticals USD 634.2M 1.2M Jun/2025
Roche Holding CHF 3.61B 381M Dec/2024
Sanofi EUR 2.63B 408M Jun/2025